Medpace (MEDP)
(Delayed Data from NSDQ)
$319.56 USD
+5.34 (1.70%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $319.71 +0.15 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$319.56 USD
+5.34 (1.70%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $319.71 +0.15 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Zacks News
Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners
by Zacks Equity Research
Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners
The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings
Near-Term Outlook Tepid for Medical Services Industry
by Urmimala Biswas
This sector witnesses growing demand for telemedicine-focused online medical services amid the pandemic.
Service Side of US Economy is Up and Running: 5 Top Picks
by Tirthankar Chakraborty
The service sector index read 58.1% in July, a 17-month high. Lest we forget, a reading above 48.5% indicates expansion of the broader economy.
Bet on These 5 Low Leverage Stocks This Earnings Season
by Zacks Equity Research
Debt is something that gives you the chills since it brings with it the burden of repayment with additional interest in the future. So investors should choose stocks prudently
3 Reasons Why Medpace (MEDP) Is a Great Growth Stock
by Zacks Equity Research
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Medpace (MEDP) Q2 Earnings and Revenues Top Estimates (Revised)
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 61.90% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Medpace (MEDP) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 52.38% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Medpace (MEDP) This Earnings Season?
by Zacks Equity Research
Medpace (MEDP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Medpace (MEDP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Q1 Earnings Miss Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of -1.30% and 1.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Up 49% Year to Date: Will the Rally Continue?
by Zacks Equity Research
Teladoc (TDOC) benefits from its fast growing healthcare business and international expansion.
Company News for Feb 26, 2020
by Zacks Equity Research
Companies In The News Are: HPQ, KEYS, MEDP, MIC.
Medpace (MEDP) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 13.33% and 3.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Medpace (MEDP) Q3 Earnings Meet Estimates
by Zacks Equity Research
Medpace (MEDP) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FYC
Should Teladoc Worry About Amazon's Virtual Healthcare Move?
by Zacks Equity Research
Teladoc (TDOC) might face increasing competition from Amazon in virtual healthcare space once the latter expands its presence.
The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia
5 Must-Buy Mid-Cap Stocks Amid Global Economic Fluctuations
by Nalak Das
Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy during market fluctuations.
U.S. Private Sector Adds New Jobs: 5 Gainers
by Zacks Equity Research
Nonfarm payroll reports show jobs addition in the private sector, these are five stocks to add to your portfolio.
Teladoc Gains on Growing Acceptance for TeleHealth Services
by Zacks Equity Research
Teladoc's (TDOC) extensive ecosystem and infrastructure poise it well for long-term growth in the expanding telehealth industry.
Medpace (MEDP) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Teladoc Up 33% Year to Date: Will the Momentum Continue?
by Zacks Equity Research
Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.
The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data